CAS 333754-36-2|Tesetaxel

Introduction：Basic information about CAS 333754-36-2|Tesetaxel, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.

Table of Contents

1. Names
2. Tesetaxel BiologicalActivity
3. Chemical & Physical Properties
4. Synonyms

Common Name	Tesetaxel
CAS Number	333754-36-2	Molecular Weight	881.99
Density	/	Boiling Point	/
Molecular Formula	C₄₆H₆₀FN₃O₁₃	Melting Point	/
MSDS	/	Flash Point	/

Names

Name	Tesetaxel
Synonym	More Synonyms

Tesetaxel BiologicalActivity

Description	Tesetaxel is a orally active, semisynthetic microtubule inhibitor of the taxane class for the treatment of cancer, including colorectal and gastric cancer.
Related Catalog	Research Areas >>CancerSignaling Pathways >>Cell Cycle/DNA Damage >>Microtubule/TubulinSignaling Pathways >>Cytoskeleton >>Microtubule/Tubulin
References	[1]. Shionoya M, Jimbo T, Kitagawa M, Soga T, Tohgo A. DJ-927, a novel oral taxane, overcomes P-glycoprotein-mediated multidrug resistance in vitro and in vivo. Cancer Sci. 2003;94(5):459-466. [2]. Saif MW, Sarantopoulos J, Patnaik A, Tolcher AW, Takimoto C, Beeram M. Tesetaxel, a new oral taxane, in combination with capecitabine: a phase I, dose-escalation study in patients with advanced solid tumors. Cancer Chemother Pharmacol. 2011;68(6):1565-1573.

Description

Tesetaxel is a orally active, semisynthetic microtubule inhibitor of the taxane class for the treatment of cancer, including colorectal and gastric cancer.

Related Catalog

Research Areas >>CancerSignaling Pathways >>Cell Cycle/DNA Damage >>Microtubule/TubulinSignaling Pathways >>Cytoskeleton >>Microtubule/Tubulin

References

[1]. Shionoya M, Jimbo T, Kitagawa M, Soga T, Tohgo A. DJ-927, a novel oral taxane, overcomes P-glycoprotein-mediated multidrug resistance in vitro and in vivo. Cancer Sci. 2003;94(5):459-466.

[2]. Saif MW, Sarantopoulos J, Patnaik A, Tolcher AW, Takimoto C, Beeram M. Tesetaxel, a new oral taxane, in combination with capecitabine: a phase I, dose-escalation study in patients with advanced solid tumors. Cancer Chemother Pharmacol. 2011;68(6):1565-1573.

Chemical & Physical Properties

Molecular Formula	C₄₆H₆₀FN₃O₁₃
Molecular Weight	881.99
InChIKey	MODVSQKJJIBWPZ-VLLPJHQWSA-N
SMILES	CC(=O)OC12COC1CCC1(C)C3OC(CN(C)C)OC3C3=C(C)C(OC(=O)C(O)C(NC(=O)OC(C)(C)C)c4ncccc4F)CC(O)(C(OC(=O)c4ccccc4)C12)C3(C)C

Synonyms

(2R,4S,6S,7R,10R,13S,14R,15S,16S,18S)-13-Acetoxy-4-[(dimethylamino)methyl]-18-{[(2R,3S)-3-(3-fluoro-2-pyridinyl)-2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)propanoyl]oxy}-16-hydroxy-7,19,2 ;0,20-tetramethyl-3,5,11-trioxapentacyclo[14.3.1.0.0.0]icos-1(19)-en-15-yl benzoate

2-Pyridinepropanoic acid, β-[[(1,1-dimethylethoxy)carbonyl]amino]-3-fluoro-α-hydroxy-, (2aS,2bR,3S,4S,6S,8aR,10S,11aS,11bR,13aR)-2a-(acetyloxy)-3-(benzoyloxy)-10-[(dimethylamino)methyl]-2a,2b,3 ,4,5,6,8a,11a,11b,12,13,13a-dodecahydro-4-hydroxy-7,11b,14,14-tetramethyl-4,8-methano-2H-[1,3]dioxolo[3,4]cyclodeca[1,2-d]-1-benzoxet-6-yl ester, (αR,βS)-

Tesetaxel

Recommended......